Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy

NCT02310867 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Immunosuppression

Interventions

DRUG: Belatacept
PROCEDURE: Hand transplant

Sponsor

Linda Cendales